Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Ng2+ perivascular cells in mouse skin come from specific fibroblast types and help in tissue repair.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Human thymus has stem cells that can self-renew and maintain their identity.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Deleting TNFα gene reduces skin cancer risk in certain mice.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Certain immune cells, when activated by specific signals, can encourage hair growth.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

CD200 is not a reliable marker for identifying stem cells in all skin types.